It doesn't look like we will get any news prior to the release of CKD data from the late-breaking session later this month (virus issues notwithstanding).  If there have been partnership or buyout discussions going on in the past couple of months there would be a host of issues to hammer out prior to an announcement. For example, being a new science the acquiring company would presumably want to know that the RVX key research personnel, who would all become newly minted multi-millionaires, are still available to further product development through to commercialization. Then there are board approvals once a price has been agreed, etc......although that shouldn't take long.  But one thing (IMO) is certain, it's either going to be a partnership arrangement or a buyout that will keep things going and one or the other is going to impact the pps in a very positive way.  There is no chance that the doors will close on RVX so really it can't be any other way.

So yes Tada, I have to agree when you said a few weeks ago something about RVX being one of the best stocks to own right now.  For sure we'll know what's what soon enough.